Shares of Hikma Pharmaceuticals PLC HIK inched up 0.33% to £18.37 Monday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.65% to ...

Shares of Hikma Pharmaceuticals PLC HIK rallied 1.64% to £18.01 Thursday, on what proved to be an all-around poor trading ...

The company also reiterated guidance for its Branded business of revenue in the high-single digits, or 6% to 8% higher year-on-year, with a core operating margin around 25%. Its Generics business is ...

Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...

Hawaii Fluid Art, a new art studio in northwest San Antonio, is now offering classes. Owners Harini and Karthik Kura opened the studio in late September and hold classes tailored to all levels of ...

https://www.tipranks.com/news/the-fly/stryker-price-target-raised-to-400-from-360-at-canaccord The Committee discusses Lexicon (LXRX) Pharmaceuticals’ New Drug ...

InMed Pharmaceuticals (INM) has released an update. InMed Pharmaceuticals has filed an international patent application for INM-901, a small molecule drug candidate aimed at treating ...

This move reflects the company’s strategic efforts to expand its market presence and offers a new opportunity for investors interested in the pharmaceutical sector. For further insights into AU ...

A new piece of artwork has been unveiled at Hull's Trinity Market ahead of Remembrance Day. Nature's Silent Casualties was put on display on October 25 and will be in place until November 18 ...

A new piece of artwork has been unveiled at Hull's Trinity Market ahead of Remembrance Day. Nature's Silent Casualties was put on display on October 25 and will be in place until November 18, not only ...

Lucy Pittaway with her new creation 'Tree of Hope' Determined to continue to honour the legacy of the Sycamore Gap tree and contribute trees across the UK and further afield, Lucy has now created ...

The agreement focuses on the discovery, co-development and licensing of new targets that could address neuropsychiatric conditions. Credit: wavebreakmedia ...